跳至主要内容
临床试验/NL-OMON47808
NL-OMON47808已完成不适用

Primary Radioactive Iodine Seed localisation in the Axilla in axillary node positive breast cancer combined with Sentinel node procedure (RISAS) following neoadjuvant chemotherapy (NAC): a novel surgical approach to accurately assess axillary response to neoadjuvant systemic therapy, thereby reducing future need for completion axillary lymph node dissection and subsequent morbidity - RISAS procedure in node positive breast cancer following NAC

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 248 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
248

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Female patient with pathologically confirmed axillary lymph node positive
  • invasive primary breast cancer, treated with neoadjuvant chemotherapy
  • 2. Willing and able to undergo all study procedures
  • 3. Has personally provided written informed consent

排除标准

  • 1. Age < 18
  • 2. Pregnancy or lactation
  • 3. Contra indication for undergoing SLNB, such as allergic reaction on 99m
  • Technetium or patent blue.
  • 4. Recurrent breast cancer
  • 5. Previous axillary surgery or radiotherapy, (e.g. Hodgkin disease treatment)
  • 6. Patients with periclavicular lymph node metastases (cN3)
  • 7. Patients with advanced breast cancer (i.e. patients with distant metastases,
  • treated without any further surgical procedures)

研究者

相似试验

Primary Radioactive Iodine Seed localisation in the... | 临床试验